Intrinsic Value of S&P & Nasdaq Contact Us

Lonza Group AG LZAGF OTC

Other OTC • Healthcare • Medical - Diagnostics & Research • CH • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Lonza Group AG (LZAGF) trades at a trailing P/E of 50.9, forward P/E of 38.4. Trailing earnings yield is 1.97%, forward earnings yield 2.60%. PEG 0.99 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 50.9).
  • Forward P/E 38.4 (down from trailing 50.9) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.99 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.97% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.60% as earnings recover.

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
57/100
→ Income
~
GROWTH
45/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — LZAGF

Valuation Multiples
P/E (TTM)50.9
Forward P/E38.4
PEG Ratio0.99
Forward PEG1.19
P/B Ratio0.00
P/S Ratio7.39
EV/EBITDA0.0
Per Share Data
EPS (TTM)$13.51
Forward EPS (Est.)$17.89
Book Value / Share$0.00
Revenue / Share$92.98
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.97%
Forward Earnings Yield2.60%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $5.28 $4.13B $301M 7.3%
2017 $10.33 $5.11B $707M 13.8%
2018 $7.48 $5.54B $559M 10.1%
2019 $10.14 $5.92B $645M 10.9%
2020 $11.63 $4.51B $869M 19.3%
2021 $39.52 $5.41B $2.94B 54.4%
2022 $16.34 $6.22B $1.22B 19.5%
2023 $8.88 $6.72B $654M 9.7%
2024 $8.92 $6.57B $636M 9.7%
2025 $13.51 $6.53B $949M 14.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message